Skip to main content
. 2020 Jan 8;65(8):536–547. doi: 10.1177/0706743719895193

Table 2.

Characteristics of the Surveyed EIS for FEP in Quebec, as of 2016.

Program characteristics Program Name 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Implementation year 1999 1988 2002–2003 2010 1999 1994 2009 2014 2014 2004 2009 2001 2014 2014 2009 2005 2005
Location Large city Large city Large city Large city Large city Large city Large city Small city/rural area Small city/rural area Small city/rural area Small city/rural area Small city/rural area Suburban area Suburban area Large city Large city Large city
Population covered 225,000 370,000 400,000 150,000 600,000 600,000 125,000 100,000 85,000 77,000 192,000 200,000 120,200 160,000 59,000 Québec, supra-regional 300,000
Program statistics Referrals per year 90 155 156 30 50 70 32 28 15 30 20 35 53 50 50
Accepted new cases per year 67 140 55 25 45 55 24 17 12 25 12 32 25 50
Accepted new cases per year per 100,000 population 30 38 14 17 8 9 24 20 16 13 6 27 42
Services Program duration 5 years 5 years 2 years 2 years 3 years > 5 years 5 years 5 years 5 years 3 years 5 years 5 years 3 years 3 years 3 years No maximum No maximum
Services for UHR patients No No Yes No No No No No Yes No No Yes Yes No No Yes Yes
Specific hospital beds 6 12 10 Yes 10 No No No No 3 No No No No 8 Yes Yes
Patient to case manager ratio 30:1 No case management 19–23:1 15–20:1 8–20:1 No case management 20:1 17:1 25:1 15:1 NA 24:1 16–18:1 10:1 NA
Admission criteria Age range 17–30 18–35 14–35 16–35 18–30 18–30 13–30 14–28 16–35 15–28 18–35 17–35 17–35 12–17 < 17 6–17
Maximum length of psychosis prior to treatment No maximum No maximum No maximum No maximum No maximum No maximum No maximum No maximum No maximum No maximum 2 years 2 years No maximum No maximum No maximum No maximum No maximum
Maximum length of prior treatment with ATP medication 1 year 5 years 1 month 1 month 6 months No maximum 1 month No maximum 2 years No maximum No maximum No maximum 6 months 6 months 1month No maximum No maximum
Inclusion of affective psychosis Yes No Yes Yes No No Yes Yes Yes No Yes Yes Yes Yes Yes Yes No
Inclusion of substance-induced psychosis Yes Yes No Yes Yes Yes No Yes Yes Yes Yes No Yes No No Yes No
Inclusion of concurrent of acquired brain injury/developmental disorders No No No No No Yes No Yes Yes No No No No Yes Yes Yes Yes
Inclusion of concurrent epilepsy Yes Yes Yes No No Yes Yes Yes Yes Yes No Yes Yes Yes Yes Yes Yes
Inclusion of concurrent mental retardation Yes No No No Yes, if mild No Yes Yes No No No No Yes Yes, if mild No Yes No
Inclusion despite legal problems No No No No No No No No No No No No No No Yes No
Accessibility/early detection School, community clinic or self-referral are accepted Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes No Yes Yes Yes No
Targeted maximum delay after between referral and first contact with patient 24 hr 2 weeks 3 days 4 days 1 month No maximum 1 week 3 days 3 days 3 days 1 week 1 week 1 week No maximum No maximum
Targeted maximum delay after between referral and face-to-face full assessment 2 weeks 2 weeks 1 week 2 weeks No maximum No maximum 1 week 2 weeks 1 week 1 week 1 week 1 week 1 week No maximum No maximum
Targeted maximum delay after between referral and entry into program 2 weeks 2 months 2 weeks No maximum No maximum No maximum 1 week No maximum 1 week 3 months 3 weeks No maximum 1 week No maximum No maximum
Average time for entry into program 1 week 1 month 1 week 1 week 1,5 month 1 month 2 days 1 month 3–4 days 1 month 3 weeks 5 days 24 hours 1–2 weeks 2–3 weeks
Public education No Yes Yes No Yes No No Yes Yes Yes Yes No No Yes No No
Direct education of sources of referral No Yes Yes Yes Yes Yes No Yes Yes No Yes Yes Yes No No Yes
Standardized processes Use of clinical practice guidelines Yes Yes Yes Yes No No Yes Yes Yes Yes Yes No No Yes Yes Yes
Formal protocol for initial assessment No No Yes No Yes No No Yes No No No No No Yes No
Regular use of standardized evaluation tools Yes No Yes Yes Yes No No No No Yes Yes Yes No Yes Yes
Formal process for evaluation of patient and treatment outcome Yes No Yes No Yes No No No No No No No No Yes No
Evaluation for quality assurance Yes No Yes No Yes No No Yes No Yes No No No No No
Education and research Continuing education within program Yes No Yes No Yes Yes Yes Yes Yes No Yes Yes Yes Yes No
Research within program Yes Yes Yes Yes Yes Yes No No No No No No No Yes No
Patient characteristics Average age at admission 23 24,5 23 22 21 18 20 19 23 22 22 15 15,5 16
% studying at admission 25 50 15 22 25 20 25 60 50 98 95 95
% working at admission 45 20 15 20 25 50 25 20 50 0 3 0
% living with their family at admission 40 60 80 70 60 67 50 60 80 95 95 95
% living independently at admission 55 40 20 30 40 33 50 40 20 1 0 0
First Nation (%) 0 1 2 2 0 0 10 0 0 0 0 25 2 0
Visible minorities (%) 33 60 35 15 15 1 0 5 1 0 10 25 5 80
First-generation immigrants (%) 25 40 18 35 15 0 0 0 0 5 10 2 10
Second-generation immigrants (%) 20 15 48 25 5 0 0 0 0 10 15 4 70
Use of antipsychotics < 1 month prior to admission 35 N/A 3 95 40 99 90 20 70 N/A 95 70
Use of antipsychotics 1–3 months 35 N/A 1 5 40 10 30 15 N/A 5 15
Use of antipsychotics 3–6 months 20 N/A 0 0 15 0 20 10 N/A 0 3
Use of antipsychotics > 6 months 10 N/A 0 0 5 0 20 5 N/A 0 2

Note. EIS = early intervention services; UHR = ultrahigh risk.